Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation.
This study analyzed the relations and time-related changes in eligibility for cardiac resynchronization therapy and prophylactic defibrillator implantation in 161 potential candidates for heart transplantation. Although up to 62% of patients who fulfilled the severity criteria for heart transplantation were eligible for either device, this percentage increased as clinical/instrumental parameters of heart failure severity worsened.
Pedone
Chiara
C
Institute of Cardiology, University Hospital S. Orsola Malpighi, Bologna, Italy.
Grigioni
Francesco
F
Boriani
Giuseppe
G
Lofiego
Carla
C
Vassallo
Pier Luigi
PL
Potena
Luciano
L
Coccolo
Fabio
F
Magnani
Gaia
G
Biffi
Mauro
M
Martignani
Cristian
C
Frabetti
Lorenzo
L
Zannoli
Romano
R
Magelli
Carlo
C
Branzi
Angelo
A
D000328:Adult; D000368:Aged; D002304:Cardiac Pacing, Artificial; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D004608:Eligibility Determination; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome